1.Flanigan R C, Campbell S C, Clark J I, et al. Metastatic renal cell carcinoma[J]. Current treatment options in oncology, 2003, 4(5): 385-390.
2. 陆旭伟, 凡杰. 肾癌干细胞研究进展[J]. 现代肿瘤医学 2010, 18(1):176-178.
3.Lin J C, Liao S K, Lee E H, et al. Molecular events associated with epithelial to mesenchymal transition of nasopharyngeal carcinoma cells in the absence of Epstein-Barr virus genome[J]. J Biomed Sci, 2009, 16(1): 105.
4.De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression[J]. Nature Reviews Cancer, 2013, 13(2): 97-110.
5.Bates R C, DeLeo III M J, Mercurio A M. The epithelial–mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis[J]. Experimental cell research, 2004, 299(2): 315-324.
6.Li X J, Peng L X, Shao J Y, et al. As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial–mesenchymal transition and activation of AKT signaling[J]. Carcinogenesis, 2012, 33(7): 1302-1309.
7.Fernando R I, Castillo M D, Litzinger M, et al. IL-8 signaling plays a critical role in the epithelial–mesenchymal transition of human carcinoma cells[J]. Cancer research, 2011, 71(15): 5296-5306.
8.Palena C, Hamilton D H, Fernando R I. Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment[J]. Future Oncology, 2012, 8(6): 713-722.
9.Li F, Yin X, Luo X,et al.Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.Cell Signal. 2013,25(6):1413-22.
10.Dobbin Z C, Landen C N. The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer[J]. International journal of molecular sciences, 2013, 14(4): 8213-8227. |